loadpatents
name:-0.015241146087646
name:-0.0047948360443115
name:-0.00136399269104
BAE; Hyun-Su Patent Filings

BAE; Hyun-Su

Patent Applications and Registrations

Patent applications and USPTO patent grants for BAE; Hyun-Su.The latest application filed is for "targeting m2-like tumor-associated macrophages by using melittin-based proapoptotic peptide".

Company Profile
1.5.14
  • BAE; Hyun-Su - Seoul KR
  • Bae; Hyun-Su - Icheon-si KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Targeting M2-like Tumor-associated Macrophages By Using Melittin-based Proapoptotic Peptide
App 20210244823 - BAE; Hyun-Su ;   et al.
2021-08-12
Cell Therapy Composition For Preventing Or Treating Neurodegenerative Disease Comprising Regulatory T Cells As Active Ingredient
App 20200030376 - Bae; Hyun-Su ;   et al.
2020-01-30
Apparatus, server, system and method for energy measuring
Grant 10,139,437 - Choe , et al. Nov
2018-11-27
Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
Grant 9,956,270 - Bae , et al. May 1, 2
2018-05-01
Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
Grant 9,919,035 - Bae , et al. March 20, 2
2018-03-20
Pharmaceutical Composition Comprising Bee Venom-phospholipase A2 (bv-pla2) For Treating Or Preventing Diseases Related To Degradation Of Abnormal Regulatory T Cell Activity
App 20170173120 - Bae; Hyun Su ;   et al.
2017-06-22
Pharmaceutical Composition Comprising Bee Venom-phospholipase A2 (bv-pla2) For Treating Or Preventing Diseases Related To Degradation Of Abnormal Regulatory T Cell Activity
App 20170165328 - Bae; Hyun Su ;   et al.
2017-06-15
Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
Grant 9,526,767 - Bae , et al. December 27, 2
2016-12-27
Apparatus, Server, System And Method For Energy Measuring
App 20150355246 - CHOE; Jong-Woong ;   et al.
2015-12-10
Pharmaceutical Composition Comprising Bee Venom-phospholipase A2 (bv-pla2) For Treating Or Preventing Diseases Related To Degradation Of Abnormal Regulatory T Cell Activity
App 20150150951 - Bae; Hyun Su ;   et al.
2015-06-04
Metal Insulator Metal Capacitor And Method Of Manufacturing The Same
App 20090001514 - Bae; Hyun-Su
2009-01-01
Herb Composition for Asthma Maintenance Therapy and Manufacturing Method Thereof
App 20080317879 - Jung; Sung-Ki ;   et al.
2008-12-25
Nelumbinis Semen Extract for Preventing and Treating Ischemic Heart Disease and Pharmaceutical Composition and Health Food Containing the Same
App 20080044505 - Bae; Hyun-Su ;   et al.
2008-02-21
Acorus Gramineus Soland Extract for Preventing and Treating Ischemic Heart Disease and Pharmaceutical Composition and Health Food Containing the Same
App 20080038380 - Bae; Hyun-Su ;   et al.
2008-02-14
Poncirus Trifoliata Extract for Preventing and Treating Ischemic Heart Diseases and Pharmaceutical Composition and Health Food Containing the Same
App 20080003269 - Bae; Hyun-Su ;   et al.
2008-01-03
Extract Of Nelumbinis Semen For The Treatment Of Depression, Medicinal Composite And Health Foods Including The Extract Of Nelumbinis Semen
App 20070207230 - Bae; Hyun-Su ;   et al.
2007-09-06
Yeast transformed with cdna of deer velvet antler for the production of efficient pharmacological ingredients and the preparation of the transformed yeast
App 20030100066 - Bae, Hyun-Su
2003-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed